Limb girdle dystrophy

Published on 02/04/2015 by admin

Filed under Internal Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1031 times

65 Limb girdle dystrophy

Advanced-level questions

What is the mode of inheritance?

Traditionally, it was believed to be autosomal recessive, with males and females equally affected. More recently,the limb girdle muscular dystrophies (LGMDs) have been identified to be inherited either in an autosomal dominant (type 1) or autosomal recessive (type 2) pattern. Six subtypes of the dominant LGMDs (1A to 1F) and 11 subtypes of the recessive LGMDs (2A to 2K) have been reported. In four of the limb girdle dystrophies (2C, 2D, 2E and 2F), mutations affecting the sarcoglycan complex of proteins have been identified. These membrane proteins interact with dystrophin through another transmembrane protein, β-dystroglycan. Dysferlin is a sarcolemmal protein, and its deficiency causes proximal and distal forms of recessively inherited muscular dystrophies, designated as LGMD type 2B.

LGMD2A, the most prevalent form, accounts for at least 30% of all cases and is caused by mutations in CAPN3 (also called p94), which encodes CAPN3, the largely skeletal-muscle-specific member of the calpain superfamily. These patients have symmetrical and selective involvement of proximal limb girdle muscles. They have normal intelligence and no cardiac or facial disturbances. The disease shows wide intrafamilial and interfamilial clinical variability. A dystrophic or myopathic process is seen on muscle biopsy. During the active phase, the serum level of creatine kinase is moderately or markedly increased; however, patients with a normal serum level of creatine kinase or a neurogenic pattern on electromyography have also been reported, suggesting that there is a spectrum of variability in this calpainopathy. Intramuscular administration of the synthetic calpain inhibitor leupeptin to dystrophic Mdx mice can prevent decreases in muscle fibre diameter (Muscle Nerve 2000;23:106–11). Calpain inhibitors, therefore, have the potential of being beneficial in this condition.